Dr. in Biology
Bestätigte E-Mail-Adresse bei
Zitiert von
Zitiert von
Vascular endothelial growth factor and interleukin-6 in paracrine tumor-stromal cell interactions in multiple myeloma
B Dankbar, T Padró, R Leo, B Feldmann, M Kropff, RM Mesters, H Serve, ...
Blood, The Journal of the American Society of Hematology 95 (8), 2630-2636, 2000
Increased angiogenesis in the bone marrow of patients with acute myeloid leukemia
T Padró, S Ruiz, R Bieker, H Bürger, M Steins, J Kienast, T Büchner, ...
Blood, The Journal of the American Society of Hematology 95 (8), 2637-2644, 2000
Atherosclerosis, platelets and thrombosis in acute ischaemic heart disease
L Badimon, T Padró, G Vilahur
European Heart Journal: Acute Cardiovascular Care 1 (1), 60-74, 2012
Lipoprotein (a) levels in familial hypercholesterolemia: an important predictor of cardiovascular disease independent of the type of LDL receptor mutation
R Alonso, E Andres, N Mata, F Fuentes-Jiménez, L Badimón, ...
Journal of the American College of Cardiology 63 (19), 1982-1989, 2014
Depression and coronary heart disease: 2018 position paper of the ESC working group on coronary pathophysiology and microcirculation
V Vaccarino, L Badimon, JD Bremner, E Cenko, J Cubedo, M Dorobantu, ...
European heart journal 41 (17), 1687-1696, 2020
Predicting cardiovascular events in familial hypercholesterolemia: the SAFEHEART registry (Spanish Familial Hypercholesterolemia Cohort Study)
L Perez de Isla, R Alonso, N Mata, C Fernández-Pérez, O Muñiz, ...
Circulation 135 (22), 2133-2144, 2017
C-reactive protein in atherothrombosis and angiogenesis
L Badimon, E Peña, G Arderiu, T Padró, M Slevin, G Vilahur, ...
Frontiers in immunology 9, 430, 2018
Lipoproteínas, plaquetas y aterotrombosis
L Badimón, G Vilahur, T Padró
Revista espanola de cardiologia 62 (10), 1161-1178, 2009
Nutraceuticals and atherosclerosis: human trials
L Badimon, G Vilahur, T Padro
Cardiovascular therapeutics 28 (4), 202-215, 2010
Overexpression of vascular endothelial growth factor (VEGF) and its cellular receptor KDR (VEGFR-2) in the bone marrow of patients with acute myeloid leukemia
T Padro, R Bieker, S Ruiz, M Steins, S Retzlaff, H Bürger, T Büchner, ...
Leukemia 16 (7), 1302-1310, 2002
ESC Working Group on Coronary Pathophysiology and Microcirculation position paper on ‘coronary microvascular dysfunction in cardiovascular disease’
T Padro, O Manfrini, R Bugiardini, J Canty, E Cenko, G De Luca, ...
Cardiovascular research 116 (4), 741-755, 2020
Circulating and platelet-derived microparticles in human blood enhance thrombosis on atherosclerotic plaques
R Suades, T Padró, G Vilahur, L Badimon
Thrombosis and haemostasis 108 (12), 1208-1219, 2012
Endotoxin induction of plasminogen activator and plasminogen activator inhibitor type 1 mRNA in rat tissues in vivo.
PH Quax, CM van den Hoogen, JH Verheijen, T Padro, R Zeheb, ...
Journal of Biological Chemistry 265 (26), 15560-15563, 1990
Stable remission after administration of the receptor tyrosine kinase inhibitor SU5416 in a patient with refractory acute myeloid leukemia
RM Mesters, T Padró, R Bieker, M Steins, M Kreuter, M Göner, S Kelsey, ...
Blood, The Journal of the American Society of Hematology 98 (1), 241-243, 2001
Paracrine interactions of basic fibroblast growth factor and interleukin-6 in multiple myeloma
G Bisping, R Leo, D Wenning, B Dankbar, T Padró, M Kropff, C Scheffold, ...
Blood, The Journal of the American Society of Hematology 101 (7), 2775-2783, 2003
Coronary heart disease, peripheral arterial disease, and stroke in familial hypercholesterolaemia: insights from the SAFEHEART Registry (Spanish Familial Hypercholesterolaemia …
L Pérez de Isla, R Alonso, N Mata, A Saltijeral, O Muñiz, P Rubio-Marin, ...
Arteriosclerosis, Thrombosis, and Vascular Biology 36 (9), 2004-2010, 2016
Role of platelet-derived microvesicles as crosstalk mediators in atherothrombosis and future pharmacology targets: a link between inflammation, atherosclerosis, and thrombosis
L Badimon, R Suades, E Fuentes, I Palomo, T Padró
Frontiers in pharmacology 7, 293, 2016
Infarction of tumor vessels by NGR-peptide–directed targeting of tissue factor: experimental results and first-in-man experience
R Bieker, T Kessler, C Schwöppe, T Padró, T Persigehl, C Bremer, ...
Blood, The Journal of the American Society of Hematology 113 (20), 5019-5027, 2009
Clinical characteristics and evaluation of LDL-cholesterol treatment of the Spanish Familial Hypercholesterolemia Longitudinal Cohort Study (SAFEHEART)
N Mata, R Alonso, L Badimón, T Padró, F Fuentes, O Muñiz, ...
Lipids in health and disease 10, 1-7, 2011
Atherosclerosis and thrombosis: insights from large animal models
G Vilahur, T Padro, L Badimon
BioMed research international 2011 (1), 907575, 2011
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20